Neurorecovery and Neuroplasticity

Date/Time: Sunday, October 23, 2022 - 3:30 PM – 5:30 PM
Track: Cross-Cutting Special Interest Group
Log in to Add to My Schedule


As the first session of the new Neuorecovery SIG, this session will develop a consensus of what neurorecovery is across neurological diseases, how this is studied, emerging principles, and directions forward. Topics covered will include mechanisms of recovery in the setting of stroke, multiple sclerosis, and spinal cord injury, spanning domains including motor and cognitive function.

Chair: S. Thomas Carmichael, MD, PhD, FANA

Co-Chair: Steve C. Cramer, MD, FANA


  • Following this session, learners will be better prepared to discover or understand the mechanisms of nervous system repair, develop valid outcome measures and clinical trials for emerging therapies, integrate the protocols in clinical trials and the understanding of nervous repair biology with the activity patterns of patients with these diseases and in the rehabilitation of these diseases.  

Defining Neurorecovery and Moving the Field Forward


Promoting Remyelination in MS: Oligodendroglial Biology to Clinical Translation


Strategies for Limiting and Repairing Damage after Traumatic Injury to the Nervous System


Neuroplasticity and Neurorecovery of Aphasia


Intensive Rehabilitation Therapy Using Telehealth Methods Early After Stroke

Poster Presenter: Steven Cramer, MD, MMSc, University of California, Los Angeles 

Myoelectric Interface for Neurorehabilitation (MINT) Conditioning Improves Arm Function in Severely Impaired Chronic Stroke Survivors

Poster Presenter: Marc Slutzky, MD, PhD, Northwestern University